CAMBRIDGE, Mass., June 6, 2008 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that management will present a company overview at several upcoming conferences.
* Vito Palombella, Ph.D., vice president, drug discovery, will present at the Seventh Annual Needham & Company Biotechnology and Medical Technology Conference in New York on June 12, 2008 at 10:30 a.m. EDT. * Steven. H. Holtzman, chair, president and chief executive officer, will present at the Piper Jaffray Europe Conference in London on June 25, 2008 at 1:20 p.m. local time (8:20 a.m. EDT). * Julian Adams, president of R&D and chief scientific officer, will present at the Jefferies 2nd Annual Healthcare Conference in New York on June 25, 2008 at 2:00 p.m. EDT.
A live webcast of each of these presentations will be accessible in the Investor Relations section of the company's website at http://www.infi.com. A replay of each presentation will also be available on the company's website for 30 days from the date of presentation.
About Infinity Pharmaceuticals, Inc.
Infinity is an innovative cancer drug discovery and development company that is seeking to leverage its strength in small molecule drug technologies to discover, develop, and deliver to patients best-in-class medicines for the treatment of cancer and related conditions. For more information on Infinity, please refer to the company's website at http://www.infi.com.
INFI-G